JS

Julli Singh

Active Director Director DIN 08255138
DIN 08255138 First appointment Oct 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value •••• Premium profile

About Julli Singh

Data last updated:

Julli Singh is a Director at Rudrahealth Bio Science Private Limited (since 2018). The company operates in Healthcare. Rudrahealth Bio Science Private Limited reported revenue of ₹5.2 Lakh (FY 2021).

DIN 08255138
Primary Designation Director
Industry Healthcare
First Appointment 11 Oct 2018
Oldest Company Age 8 yrs
Largest company Rudrahealth Bio Science Private Limited · ₹5.2 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Oct 20182018₹5.2 Lakh (FY 2021)Active

Board colleagues of Julli Singh

Directorship timeline

Open interactive timeline →
Rudrahealth Bio Science Private Limited
Premium access

Shareholding and investment profile for Julli Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Julli Singh

Julli Singh currently holds 1 directorship: Rudrahealth Bio Science Private Limited (Director, since 11 Oct 2018, revenue ₹5.2 Lakh (FY 2021)).

Julli Singh was first appointed on 11 Oct 2018 as Director at Rudrahealth Bio Science Private Limited.

The current boards of Julli Singh's companies include Karuna Singh (Rudrahealth Bio Science Private Limited), Madhwendra Kumar Singh (Rudrahealth Bio Science Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available